Home » Volumes » Volume 23 January/February 1990 » Risco de desenvolver câncer em receptores de sangue violetado. Validade da entrevista

Risco de desenvolver câncer em receptores de sangue violetado. Validade da entrevista

Prof. Vicente Amato Neto; Dr. Jacyr Pasternak

Universidade de São Paulo

DOI: 10.1590/S0037-86821990000100010


Texto completo disponível apenas em PDF.

Full text available only in PDF format.

 

 

REFERÊNCIAS BIBLIOGRÁFICAS

1. Blumberg N, Heal JM, Murphy P, Agarwal MM, Chuang C. Association between transfusions of whole blood and recurrense of cancer. British Medical Journal 293:530-533, 1986.         [ Links ]

2. Gascon P, Zoumbs NC, Young Ns. Immunologic abnormalities in patients receiving multiple blood transfusions. Annals of Internal Medicine 100:173-177, 1984.         [ Links ]

3. Hamblin T. Blood transfusions and cancer: anomalies explained? British Medical Journal 293:517-518, 1986.         [ Links ]

4. Kaplan BJ, Samaik S, Gitlin J, Lusher J. Diminished helper/supressor lymphocyte rations and natural killer activity in recipients of repeated blood transfusion. Blood The Journal of the American Society of Hematology 64:308-310, 1984.         [ Links ]

5. Selby JV, Friedman GD. Epidemiologic evidence of an association between body iron stores and risk of cancer. International Journal of Cancer 41:677-682, 1988.         [ Links ]

6. Stevens R, Jones Y, Micozzi M, Taylor PR. Body iron stores and the risk of cancer. The New England Journal of Medicine 319:1047-1052, 1988.         [ Links ]

7. Stevens RG, Beasley RP, Blumberg BS. Iron binding proteins and risk of cancer in Taiwan. Journal of the National Cancer Institute 76:605-610, 1986.         [ Links ]